Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

New antitumor, antibacterial and antifungal agents isolated from Streptomyces sp.

Sep. 27, 2004

Oxazepine-based antitumor agents newly discovered at Servier

Sep. 27, 2004

Tarceva plus gemcitabine combination improves survival in pancreatic cancer patients

Sep. 23, 2004

PD-332991 enters phase I

Sep. 23, 2004

Anticancer compound WX-671 enters clinical development

Sep. 23, 2004

Promising liver-selective thyromimetic for the treatment of hepatocellular carcinoma

Sep. 23, 2004

PPARgamma chemoprotective for mammary, ovarian and skin cancers

Sep. 22, 2004

Oxford BioMedica extends agreement for cytochrome P450 enzymes

Sep. 22, 2004

Oncology collaboration between Ablynx and Genencor

Sep. 22, 2004

Small-molecule inhibitor of beta-catenin/cyclic AMP effective in models of colon cancer

Sep. 22, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 4, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...